Venomics AI raises $2.7 million to build venom-based drug discovery tools
In short
Venomics AI has raised $2.7 million in pre-seed funding. The IISc spinout will use the money to grow its Venom Atlas database, improve AI-based drug discovery, and do more lab screening and validation.
The funding helps the company push ahead with drug discovery from animal venom. That could support its research and testing work.
What the reporting says
Venomics AI raised $2.7 million in pre-seed funding to expand its Venom Atlas molecular database and strengthen AI-led drug discovery and laboratory screening. The Business Standard summary says the IISc spinout will also validate potential drugs using the new capital. The funding supports work on discovering drugs from animal venom. No investor details were included in the source snippet.
Why it matters
Venomics AI raised $2.7 million in pre-seed funding. The IISc spinout plans to use the money to expand its Venom Atlas molecular database, strengthen AI-led drug discovery and laboratory screening, and validate potential drugs. The raise supports the company’s work on drug discovery from animal venom and its research pipeline.